COM:ALLOGENE
Allogene Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
allogene.comcrunchbase
allogene-therapeuticslinkedin
allogene-therapeuticsfounding date
Jan 01, 2017ipo date
Oct 11, 2018
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-...Show More